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Background: To achieve the goal of malaria elimination in low transmission areas such as in Cambodia, new,
inexpensive, high-throughput diagnostic tools for identifying very low parasite densities in asymptomatic carriers
are required. This will enable a switch from passive to active malaria case detection in the field.
Methods: DNA extraction and real-time PCR assays were implemented in an “in-house” designed mobile laboratory
allowing implementation of a robust, sensitive and rapid malaria diagnostic strategy in the field. This tool was
employed in a survey organized in the context of the MalaResT project (NCT01663831).
Results: The real-time PCR screening and species identification assays were performed in the mobile laboratory
between October and November 2012, in Rattanakiri Province, to screen approximately 5,000 individuals in less
than four weeks and treat parasite carriers within 24–48 hours after sample collection. An average of 240 clinical
samples (and 40 quality control samples) was tested every day, six/seven days per week. Some 97.7% of the results
were available <24 hours after the collection. A total of 4.9% were positive for malaria. Plasmodium vivax was
present in 61.1% of the positive samples, Plasmodium falciparum in 45.9%, Plasmodium malariae in 7.0% and
Plasmodium ovale in 2.0%.
Conclusions: The operational success of this diagnostic set-up proved that molecular testing and subsequent
treatment is logistically achievable in field settings. This will allow the detection of clusters of asymptomatic
carriers and to provide useful epidemiological information. Fast results will be of great help for staff in the field
to track and treat asymptomatic parasitaemic cases. The concept of the mobile laboratory could be extended
to other countries for the molecular detection of malaria or other pathogens, or to culture vivax parasites,
which does not support long-time delay between sample collection and culture.Background
In Southeast Asia, the incidence of malaria (mainly
Plasmodium falciparum) has significantly decreased in
the past ten years [1,2]. However, the emergence of arte-
misinin resistance in P. falciparum, firstly detected in
2008–2009 in western Cambodia [3-5] and confirmed in
Thailand [6], Myanmar [7] and Vietnam [8], threatens
these efforts.
In very low transmission settings such as Cambodia,
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stated.malaria parasites contributing to maintain disease trans-
mission [9-11]. As a consequence, the detection and treat-
ment of the asymptomatic carriers is a crucial step in
progress towards malaria elimination [12]. This represents
a new challenge as the proportion of asymptomatic para-
site carriers is unknown. Moreover, standard diagnostic
tools such as the rapid diagnostic test (RDT) or micros-
copy examination of a blood slide often fail to detect low
parasitaemia [13,14]. To achieve the goal of malaria
elimination in areas with low transmission intensity,
and especially in Cambodia where artemisinin-based com-
bination therapy (ACT) efficacy is declining [15], the diag-
nostic toolbox needs to be enriched with inexpensiveLtd. This is an Open Access article distributed under the terms of the Creative
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densities in asymptomatic individuals in the field. The
information acquired from such tools will enable deter-
mination of the areas of residual malaria transmission
in the country and will guide new parasite and vector
control strategies required to re-orientate national control
programmes towards the achievement of elimination [16].
Usually, routine diagnostics in the field are performed by
microscopy and/or RDT. Good RDT and well-performed
microscopy can detect parasitaemia of at least 50–200
parasites/μl [17], which is sufficient for the management
of symptomatic cases, but less informative in detecting
asymptomatic cases [13]. Moreover, microscopy remains
labour intensive and time consuming. Its quality in field
conditions is often inadequate and limited by factors such
as the quality of reagents, microscopist skill and poorly
maintained equipment. On the other hand, RDT, which is
simple to use, has several drawbacks, such as a variable
detection threshold or field stability [18]. For more than
a decade, the performance of malaria diagnostic tests
has been considerably improved with the introduction
of molecular assays [19]. Several PCR-based assays de-
tecting parasite nucleic acids have been described so far,
but surprisingly, microscopy is still recognized as the
gold standard for laboratory confirmation. The nested
PCR targeting the small subunit ribosomal RNA 18S
(18S rRNA) gene, described by Snounou et al. in 1993
[19] and improved in 1999 [20], remains the most com-
monly used method. Although PCR methods show lower
detection threshold compared to microscopy [17,21],
nested PCR assays are time consuming, very prone to
contamination and not suited for high-throughput testing.
The real-time PCR approach has the potential to over-
come these limitations, offering a simple, time-effective
and even more sensitive diagnostic option [22]. Most of
the PCR-based assays target the 18S rRNA gene [23,24],
whereas detecting mitochondrial genes such as cytochrome
b gene has been suggested to be a more sensitive approach
due to their higher copy numbers in the parasite genome
(20–100 copies) [11,25-27].
In the current study, a strategy based on real-time PCR
detection of the Plasmodium cytochrome b gene has been
developed. The rationale was to screen as a first step
samples for malaria parasites using genus-specific primers
(named “real-time PCR screening”), allowing treatment of
positive cases in <24-48 hours in field settings. In a second
step, a PCR assay capable of identifying the malaria
species was carried out on positive samples. This assay
was designed as a nested real-time PCR with four
separate reactions (P. falciparum, Plasmodium vivax,
Plasmodium malariae and Plasmodium ovale) (named
“nested real-time PCR species”). Multiplexing assay was
avoided to increase the sensitivity for detecting minor
species in mixed infections.Adaptation of the assay to large-scale epidemiologic
studies required the implementation of a rapid DNA ex-
traction technique. Blood samples were collected in the
field on filter paper in a 96-well plates format, and DNA
was extracted using a simple and fast chelex-boiling method
described previously [12]. The molecular detection method
described here was optimized and validated using in-house
controls, and compared to the 18S rRNA nested PCR on
a set of DNA samples. A quality assurance system was
developed to monitor the performance of both DNA
extraction and PCR over time.
Currently, malaria molecular diagnosis using PCR-based
method has been restricted to well-equipped laboratories.
As a consequence, this hampers its use for active malaria
case detection because the timely feedback of results
does not allow the treatment of identified cases [12]. In
the present study, DNA extraction and PCR technolo-
gies were implemented in an “in-house” designed mobile
laboratory allowing a robust, sensitive and rapid malaria
diagnostic strategy into the field. This innovative approach
has been employed in the context of a two-year study
“Repellents as added control measure to long-lasting
insecticidal nets to target the residual transmission in
Southeast Asia: a step forward to malaria elimination”
(MalaResT project, NCT01663831).Methods
Mobile laboratory
The mobile laboratory was designed in November 2011,
manufactured by FEMIL [28] in January-April 2012 and
available in Phnom Penh in August 2012. The map of the
mobile laboratory, pictures, equipment and activities are
presented in Figure 1 and Additional file 1. The mobile
laboratory has a total surface of approximately 15 sq m,
including three air-conditioned rooms (PCR room, office
and culture room) fully equipped to perform DNA extrac-
tion, real-time PCR assays, microscopy and parasite cul-
ture in a completely autonomous way.
The mobile laboratory is towed by a truck equipped
with a 15 KVA generator, eight batteries, a cabin for
three passengers, and enough storage space for equip-
ment and consumables. The total length of the convoy
is ~13 m. A system of cylinders maintains a stable hori-
zontal orientation.
During day activities, equipment can work with local
electricity supply when available, or with the generator
that automatically starts when the power is interrupted.
Sensitive devices such as real-time PCR equipment are
connected to a 3KVA UPS to overcome the transition of
electricity supply and irregular voltage. During the night
or during transport, the batteries ensure the electricity
supply of the fridge, freezers, incubator, lights and venti-
lation (3,000 watts, capacity up to ten hours back-up).
Figure 1 Design of the mobile laboratory.
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Real-time PCR screening
Plasmodium falciparum ring-stage parasites obtained from
synchronized reference 3D7 parasites cultures were used
as positive controls.
Optimization
For the optimization and evaluation of the performance
of the real-time PCR screening, 200 μl red blood cell pellet
(~3% parasitaemia) were extracted with the QIAamp
DNA Blood Mini kit® (Qiagen, Courtaboeuf, France).
DNA was eluted with 200 μl of water and DNA concentra-
tion was measured with a spectrophotometer (Nanodrop
2000®, Wilmington, USA) and adjusted at 1 ng/μl. Ten-fold
dilutions were prepared from 10-1 ng/μl to 10-6 ng/μl with
DNAse/RNAse-free water.
After optimization, two concentrations (10-1 and
10-3 ng/μl) were selected as positive controls. In parallel,
200 μl of uninfected blood were extracted by same method,
adjusted at 10-1 ng/μl and used as negative control.Threshold of detection
To assess the detection threshold of the entire process
(including DNA extraction and volume of blood analysed),
cultured 3D7 ring-stage parasites were adjusted to
approximately 1% parasitaemia and serially diluted ten-
fold using uninfected blood from the blood bank, from
1,000 to 0.01 parasites/μl. Twenty μl of each dilution
were spotted onto Whatman 3MM filter paper and air
dried. Punches of 4-mm diameter were prepared and
stored at −20°C. Blood spot confetti of uninfected blood
were also prepared to serve as negative controls. DNA
was extracted with Instagene® Matrix resin (ref. 732–6030,
Bio-Rad, Singapore). Two concentrations (high positive
control (HPC) at 500 parasites/μl and low positive control
(LPC) at 5 parasites/μl) were selected and used as positive
control in further analysis.
Real-time PCR species
For the validation of the four species-specific PCR assays,
400 bp fragment of the first round of amplification were
2 x 20 µl onto filter paper
DNA extraction Storage
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Figure 2 The overview of the process used for high-throughput malaria PCR detection in the field (Panel A), including samples and
data management (Panel B).
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P. malariae and P. ovale plasmids. Plasmid DNA concen-
trations were assessed with a spectrophotometer (Nanodrop
2000®, Wilmington, USA). A ten-fold dilution series of
each plasmid (from 10-1 ng/μl to 10-9 ng/μl) was prepared
to evaluate the efficiency of each species-specific PCR assays.
Method comparison
The real-time PCR screening and species identification as-
says were compared with the 18S rRNA nested PCR de-
scribed by Snounou et al. [24] on a cohort of 175 external
DNA samples provided by FIND [29]. These samples were
collected in 2012 in Uganda and Burkina Faso, and were
previously characterised using the 18S rRNA nested PCR.
Upon reception at IPC, all samples were blindly re-testedwith the genus-specific 18S rRNA nested PCR (rPLU1 and
rPLU 5 primers). Then, samples were screened for malaria
using the real-time PCR screening assay, and positive
samples were analysed for identification of malaria
species using the real-time PCR species assay.
High-throughput malaria PCR detection flow
An overview of the entire PCR detection process is pro-
vided in Figure 2 (Panel A).
Sample collection
Blood samples from each participating individuals were
collected in the field on filter paper from a finger prick
in two different formats: 5 μl in a 96-well plate containing
a 4-mm diameter Whatman 3MM filter paper using a
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man 3MM filter paper (Additional file 2). Blood from the
96-well plates was used for malaria screening by real-
time PCR, while 20-μl blood spots were air-dried,
wrapped in aluminium foil, and stored at −20°C (used as
back-up or for further analyses).
DNA extraction
Blood spots were lysed overnight on 96-well plates at 4°C
with 150 μl per well of HBS 1X/Saponin 0.5%. Sample
were then washed twice with HBS 1X and DNA was
extracted with Instagene® Matrix resin (Bio-Rad, Singapore)
according to manufacturer’s instructions. An additional
centrifugation step (4,000 rpm, 20 min) was added to limit
the presence of inhibitors and a final volume of 50 μl of
the supernatant was transferred into a new 96-well plate.
Real-time PCR
Molecular detection and identification of Plasmodium para-
sites were performed in two steps: Plasmodium parasites
were first detected by a “screening real-time PCR” with
genus-specific primers targeting the Plasmodium cytochrome
b gene. Secondly, DNA samples identified as positive for
Plasmodium were analysed for malaria species using a
nested real-time PCR assay. The first round of amplifica-
tion was performed with genus-specific primers in a
standard thermocycler. PCR products were then diluted
1:10 and analysed in four real-time PCR assays with
primers targeting the same gene fragment and specifics to
each species (P. falciparum, P. vivax, P. malariae, and P.
ovale). All real-time PCR assays were followed by a
melt curve analysis. Details are provided in Table 1.
Quality assurance
For each real-time PCR run, negative and positive “in
house” prepared controls were used to validate both DNA
extraction and real-time PCR runs.
For the validation of the DNA extraction, a set of six
control blood spot confetti was added in the 96-well
plate prior to the DNA extraction steps (two negative
controls and four positive controls: two HPC and two
LPC). The lowest concentrations are close to the detec-
tion limit of the test, to be sure that the detection limit
remains the same over the different tests.
For the real-time PCR screening runs, a set of four con-
trols (two DNA positive controls; a HPC and a LPC, and
two negatives; water) were added in the 96-well plate
prior to performing the real-time PCR run. Each lot of “in
house” prepared quality controls were tested and validated
at the Institut Pasteur du Cambodge (IPC) before being
used in the field studies. For the validation of the real-
time PCR species runs, the plasmid constructs previously
described were used in each PCR assays. Details are pro-
vided in Table 2.For all PCR controls, Ct values were plotted on an x-chart
to monitor assay precision deviation over time. Additionally,
all reagent lots (primers, master mix, saponin solution
and Instagene® matrix) were validated using controls at
IPC before departure on the field and then again in the
mobile laboratory prior to the start of each survey.
Ethical considerations
The entire study protocol of MalaResT project was ap-
proved by three independent ethical committees: The Insti-
tutional Review Board of Institute for Tropical Medicine
Antwerp, The Ethics Committee of the University Hospital
of Antwerp and the National Ethics Committee for Health
Research in Cambodia.
Field study: moving PCR detection in the field
Study design and objective
The malaria PCR detection method described in this
paper was applied in the context of the two-year study
“Repellents as added control measure to long lasting
insecticidals nets to target the residual transmission in
Southeast Asia: a step forwards to malaria elimination”
(NCT01663831). The purpose of this study was to raise
evidence on the effectiveness of mass use of topical repel-
lents in addition to long-lasting insecticide nets (LLINs) in
controlling malaria infections. The epidemiological efficacy
of repellents was evaluated in Rattanakiri Province, eastern
Cambodia, on the prevalence of malaria parasite carriers
detected by PCR. To achieve this goal, 98 communities
consisting of one or more neighbouring villages were
randomly assigned to one of two treatment arms (LLINs
and LLINs + repellent). Four cross-sectional surveys were
planned over a two-year period, one at the start and one
at the end of the malaria season. During each survey the
aim was to collect blood samples of 65 randomly selected
participants within each community. Results presented
here are from the survey performed in the mobile labora-
tory over a 20-day period in October-November 2012.
Data flow
Upon reception of samples in the mobile laboratory,
sample identifications were entered twice, by two techni-
cians, in a “real-time PCR worksheet”. After PCR run com-
pletion, PCR runs and worksheets were sent by email to
IPC for validation. Results were double-checked and
positive sample identifications were sent back to the field




The threshold of detection was evaluated on P. falciparum
DNA ten-fold dilutions. Linear regression analysis indi-
cated that the PCR assay has a reproducible linearity
Table 1 Primers sequences and real-time PCR conditions used to detect Plasmodium species
Real-time PCR name Primer name Sequence (5′-3′) Master mix Assay parameters Melt parameters T° melt peak
Real-time PCR screening RTPCRScreening2_F TGGAGTGGATGGTGTTTTAGA Hot FirePol EvaGreen qPCR Mix
Solis Biodyne 1X (#08-24-00020),
Primers 150 nM, 5 μl DNA template,
Total volume 20 μl











Primary PCR RTPCRScreening2_F TGGAGTGGATGGTGTTTTAGA Hot FirePol DNA Pol. Solis BioDyne
1.25 U (#01-02-01000), dNTP 200 μM,
MgCl2 2.5 mM, Primers 250 nM, 5 μl
DNA template. Total volume 20 μl.
94°C −15 min 20 cycles:
94°C-30 sec/ 58°C −1 min/






Pf_RTPCR_F ATGGATATCTGGATTGATTTTATTTATGA Hot FirePol EvaGreen HRM Mix Solis
Biodyne 1X (#08-33-00001), Primers
250 nM, 5 μl template Primary PCR
products 1:10, Total volume 20 μl







































Table 2 List of the controls used in each PCR assays for the validation of DNA extraction and/or the real-time PCR runs
QC name Number used in 96-well plates Type Concentration
PCR HPC PCR High Positive Control 1 Pf 3D7 DNA extract (QiaAmp DNA mini kit) 0.1 ng/μl
PCR LPC PCR Low Positive Control 1 Pf 3D7 DNA Extract (QiaAmp DNA mini kit) 0.001 ng/μl
PCR NC PCR Negative Control 2 H2O N/A
Ext HPC Extraction High Positive Control 2 Dried blood spot (4mmØ ) with Pf 3D7 blood 500 parasites/μl
Ext LPC Extraction Low Positive Control 2 Dried blood spot (4mmØ ) with Pf 3D7 blood 5 parasites/μl
Ext NC Extraction Negative control 2 Dried blood spot (4mmØ ) with Pf negative blood No parasite
Pf P. falciparum Positive Control 1 Plasmid (Pf 400 bp insert) 0.001 ng/μl
Pv P. vivax Positive Control 1 Plasmid (Pv 400 bp insert) 0.001 ng/μl
Pm P. malariae Positive Control 1 Plasmid (Pm 400 bp insert) 0.001 ng/μl
Po P. ovale Positive Control 1 Plasmid (Po 400 bo insert) 0.001 ng/μl
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lification was higher when an annealing temperature of
58°C was used instead of 60°C (92 and 87%, respectively).
However, the annealing temperature of 60°C was preferred
as it allowed a reduction of the background noise, facilitat-
ing results interpretation, without affecting the threshold
of detection of 10-4 ng/μl (Figure 3, Panel A).
To compare the performance of the real-time PCR
screening and the real-time PCR species, the screening assay
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Figure 3 Linear regression analysis and reproducibility of the
real-time PCR screening (Panel A) and melt temperatures (Tm)
observed for each Plasmodium species (Panel B).specific plasmids (P. falciparum, P. vivax, P. malariae,
P. ovale.), and was capable of detecting P. falciparum,
P. malariae, P. ovale plasmid DNA down to 10-8 ng/μl,
and P. vivax plasmid DNA down to 10-7 ng/μl.
Melting temperatures (Tm) were consistently higher on
P. falciparum amplicons (Tm ~78°C) compared to ampli-
cons of other Plasmodium species (Tm ~77°C for P. vivax
and Plasmodium knowlesi, Tm ~76.8°C for P. malariae
and P. ovale). The Tm ranging from 76.4 to 78.4°C was
considered specific for Plasmodium (Figure 3, Panel B).
No amplification was observed using Plasmodium nega-
tive blood (human DNA at 0.1 ng/μl).
The detection threshold of the entire method (including
sample volume analysed, DNA extraction and real-time
PCR screening) was assessed on a set of serial dilutions of
P. falciparum blood (1,000 to 0.01 parasites/μl) spotted
on filter paper. Eight replicates per dilution were tested
twice (except dilution 5 and 2 parasites/μl tested once).
On both assays, the real-time PCR screening was capable
of detecting parasite DNA in 100% of samples having a
parasitaemia at 1,000, 100, 10, 5 and 2 parasites/μl. At
1 parasite/μl, 13/16 (81%) samples were positive (7/8 in
assay 1 and 6/8 in assay 2, respectively). No amplifica-
tion curves were observed for samples at 0.1 parasite/μl
or less. The last consistently positive dilution corresponds
to 2 parasites/μl whole blood (~10 parasites on the blood
spot) (Table 3).Real-time PCR species
Plasmodium species identity for each species-specific
plasmid was confirmed by sequencing (P. ovale plasmid
corresponds to the sub-species P. o. wallikeri).Sensitivity
Plasmodium falciparum and P. vivax real-time PCR spe-
cies assays were capable of detecting plasmid DNA down
to 10-7 ng/μl, while P. malariae and P. ovale real-time
PCR species assays were 100% positive down to 10-8 ng/μl.
Table 3 Threshold of detection of the real-time PCR
screening (including sample volume analysed, DNA
extraction and real-time PCR screening): percentage of
positive results according to the dilution of parasites
Dilution
(parasites/μl)
% of positive results (No positives/No tested)
Assay 1 Assay 2 Average
1,000 100% (8/8) 100% (8/8) 100% (16/16)
100 100% (8/8) 100% (8/8) 100% (16/16)
10 100% (8/8) 100% (8/8) 100% (16/16)
5 ND 100% (8/8) 100% (8/8)
2 ND 100% (8/8) 100% (8/8)
1 87% (7/8) 75% (6/8) 81% (13/16)
0.1 0% (0/8) 0% (0/8) 0% (0/8)
0.01 0% (0/8) ND 0% (0/8)
Table 4 Performances of the real-time screening PCR and
the genus-specific 18S rRNA nested PCR: concordant and
discordant data




Positive 39 0 39
Negative 15 118 133
Total 54 118 172
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The four real-time PCR species assays showed spe-
cific amplification when tested on all different plas-
mids (0.01 ng/μl), except with P. malariae plasmid,
which showed a low amplification curve in P. vivax
real-time PCR reaction. However, no unspecific ampli-
fications were observed with higher dilution of P.
malariae plasmid.
Primers targeting P. knowlesi were originally de-
signed, but removed from the assay because they were
not specific.
When using artificial mixed infections (various concen-
trations of “targeted plasmid” with constant concentration
at 0.01 ng/μl of “added plasmid”), the performances of the
real-time PCR species were not affected, even when the
“added” plasmid was 100,000 times more concentrated
than the “targeted plasmid” (Additional file 3).
Nested real-time PCR species
In order to save DNA templates and to increase the sensi-
tivity, a nested PCR step was added using genus-specific
primers prior to the real-time PCR species. With this
additional step, only 5 μl of DNA extract was enough to
perform the four real-time PCR species (instead of
20 μl). This format was evaluated on the same dilutions
of plasmids, and showed similar or higher sensitivity
than the real-time PCR species assays.
Comparison with the 18S rRNA nested PCR
Real-time screening PCR versus genus-specific 18S rRNA
nested PCR
The real-time PCR screening assay was compared to
the 18S rRNA nested PCR on a set of 175 African
DNA samples, previously screened on-site (Uganda
and Burkina Faso) with the nested 18S rRNA PCR.
Samples were first retested with the genus-specific
primers of the 18S rRNA nested PCR at IPC and thenwith the real-time PCR screening assay. Three sam-
ples showed discordant results between the two
nested 18S rRNA PCR runs and were removed from
the panel. Among the remaining 172 samples, 23%
(39/172) were found positive with the 18S rRNA
nested PCR and 31% (54/172) with the real-time PCR
screening (Table 4, Panel A). The 15 discordant sam-
ples had the highest Ct values among the 54 samples
detected as positives by the real-time screening PCR
(concordant samples, mean Ct = 25 cycles and dis-
cordant samples, mean Ct = 35 cycles); those with a Ct
value >35 cycles were systematically negative with the
18S rRNA nested PCR, while 50% of those with a Ct
value between 30–35 cycles were found negative with
the 18S rRNA nested PCR (Table 5, Panel B).Nested real-time PCR species assay versus species-specific
18S rRNA nested PCR
The results of the 54 positive samples tested with the
real-time PCR species assay and the species-specific 18S
rRNA nested PCR are presented in Table 6 (Panel C).
Using both PCR, single P. falciparum or P. ovale infec-
tions were detected, while P. malariae was found only in
mixed infection (with P. falciparum or P. ovale or both)
and P. vivax was not detected.
Among the 39 samples found positive with both genus-
specific PCR, 35 (90%) showed concordant species results.
For the four discordant samples: three samples were de-
tected as single P. falciparum with the species-specific
18S rRNA nested PCR but as mixed infection with the
nested real-time PCR species (P. falciparum/P. malariae,
N = 2 and P. falciparum/P. ovale, N = 1) and one sample
was detected as P. falciparum with the nested real-time
PCR species but as mixed infection with the species-
specific 18S rRNA nested PCR (P. falciparum/P. ovale).
Among the 15 samples missed by the 18S rRNA nested
PCR, 75% were classified as single P. falciparum. The
nested real-time PCR species failed to amplify three
samples detected as positive using real-time screening
PCR (“P. falciparum-like Tm” (78–78.2) and Ct >36).
The most likely hypothesis is that these samples were
low positives for P. falciparum, below the limit of detec-
tion of the P. falciparum-specific real-time PCR assay
Table 5 Performances of the real-time screening PCR










16 to 29 cycles 34 34 (100%)
30 to 35 cycles 10 5 (50%)
> 35 cycles 10 0 (0%)
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appears to be better for P. falciparum).Implementation of malaria PCR detection into the field:
study results
The set-up described here was successfully implemented
in the field. From 23 October to 15 November, 2012, a
total of 4,999 blood samples were collected and screened
for malaria parasites in the mobile laboratory in Rattanakiri
Province, in northeast Cambodia. An average of 240 clinical
samples (+40 quality control samples) was tested every day,
six/seven days per week; 97.7% of the results were available
in less than 24 hours after sample collection and malaria-
positive individuals were treated in less than 48 hours after
the collection. Only 2.3% of the results (117/4,999) were
delayed due to invalid runs (which were repeated the next
morning), and were delivered in less than two working
days after the collection.Prevalence of the malaria species
Among the 4,999 collected samples, 244 samples (4.9%)
were detected positive for malaria and analysed for
malaria species identification. All the four human Plasmodium
species were detected. In general, P. vivax was present inTable 6 Performances of the real-time screening PCR and the
genus-specific 18S rRNA nested PCR: species identification









P. falciparum 31 29 9
P. ovale 2 2 2
P. falciparum/P. ovale 3 3 1




No species 0 0 3
Total 39 39 1561.1% of the positive samples, P. falciparum in 45.9%, P.
malariae in 7.0%, and P. ovale in 2.0%.
Single malaria infections were found in 86.9%. Plasmo-
dium vivax was the most prevalent single infection (49.2%)
followed by P. falciparum (34.0%), P. malariae (3.3%) and
P. ovale (0.4%). Mixed infections were also frequent (13.1%)
associating two species (P. falciparum/P. vivax, 8.6%;
P. falciparum/P. malariae, 0.8%; P. falciparum/P. ovale,
0.4%; P. vivax/P. malariae, 0.4%; P. vivax/P. ovale, 0.4%),
three species (P. falciparum/P. vivax/P. malariae, 1.6%; P.
vivax/P. malariae/P. ovale, 0.4%) or four species (0.4%).
Quality control data
Run validation was based on the results of ten internal
quality controls analysed per run (one PCR HPC, one
PCR LPC, two PCR NC, two Ext HPC, two Ext LPC,
two Ext NC, see Table 2). A total of 830 quality control
samples were analysed, representing 16% of the PCR tests
performed. As presented in Additional file 4, no false
negative and six false positives were observed: four posi-
tives out of 166 PCR negative controls and two positives
out of 166 extraction negative controls (the whole plate
was retested in these cases).
The Ct values of the 166 PCR controls were plotted on
a x-chart to follow assay precision over time and only
one PCR HPC and one PCR LPC were observed to be
out of the two standard deviation (SD) limit (Additional
file 5). The precision of the real-time PCR assay was also
assessed by the coefficient of variation (CV) and SD of
the replicate Ct measurements (n = 83 x2) for the two
PCR positive controls. The CV for the mean Ct values
obtained with the PCR HPC (mean Ct value = 21.07) and
PCR LPC (mean Ct value = 29.84) was 3.1 and 2.4%, re-
spectively, demonstrating a very low inter-assay variability
(CV <5%). The average melt Tm values were 78.08°C
(SD = 0.15 and CV% = 0.20) and 78.05°C (SD = 0.13 and
CV% = 0.16) for the HPC and the LPC, respectively.
Discussion
In the context of malaria elimination, the development
of new diagnostic approach capable to detect low infec-
tion for mass screening in field settings is essential [14].
In this study, a reliable and cost-effective molecular assay
for malaria diagnostic was adapted for high throughput
testing and transferred into a mobile laboratory.
The real-time PCR screening assay showed good ampli-
fication efficiency and was capable to detect Plasmodium
3D7 DNA as low as 10-4 ng/μl. When combined together
with the Instagen DNA extraction, the detection limit
using 5 μl of blood on dried blood spot was 2 parasites/μl.
The melt curve analysis allowed the differentiation of
falciparum from non-falciparum malaria positive samples
(melt temperatures were consistently higher for falcip-
arum amplicons compared to other species). The real-
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than the reference 18S rRNA nested PCR, by detecting
more often very low parasitaemia. This increased sensitiv-
ity is likely related to the targeted gene and the method
used to detect the PCR products. Indeed, in malaria para-
sites, the mitochondrial genome is presented at a higher
copy number than 18S rRNA gene, and, while early ring-
stage parasite typically have one mitochondrial organelle,
mature gametocytes have many. Moreover, the melt curve
analysis step following the real-time PCR allowed the
differentiation of specific/unspecific late amplification
curves (generally occurring at Ct > 35), and thus, enabled
an increase in the number of amplification cycles up to 45.
Species identification of positive samples was highly
comparable between the two PCR methods used, with
90% concordant results. The discordances observed in
four/39 samples were due to a failure to amplify the
species present at very low level in a mixed infection by
the 18S RNA nested PCR in three cases, and by the
real-time in one case. This finding suggests that the
real-time PCR species assays have an improved ability
to detect minor species in mixed infection. Indeed, plas-
mid mixing experiments showed that the presence of a
highly concentrated species did not impact the detection
of the minor species, even with a ratio of 1:100,000.
As Cambodia is a low transmission area, the adopted
strategy was to first screen for malaria positive cases using
a highly sensitive real-time PCR, followed by a species
identification of those positive samples. This approach
offers the advantages of reducing result turnaround
times and PCR costs. A first round of amplification
with genus-specific primers can be optionally added prior
to performing the four real-time PCR species assays.
Although the real-time species assays alone demonstrated
good performances when tested on quality controls (simi-
lar to the real-time screening assay), the addition of an
outer PCR was observed to be beneficial when working
with clinical samples; likely because DNA extracted by
Instagen method is not very stable and sensitive to freeze/
thaw cycles, and so, low quantities of parasites DNA may
start being degraded during the storage time between the
“screening test” and the “species test”. This additional step
also offers the advantage of reducing the quantity of DNA
templates needed to perform the analysis.
The next challenge after the validation of the method-
ology was to transfer it from the laboratory to the mobile
laboratory. In less than one month, a total of 4,999 sam-
ples were screened for malaria parasites in the province
of Ratanakiri in October-November 2012. Five four-
person teams conducting sample collections and two
laboratory technicians were permanently present in the
field. The technicians typically performed four DNA ex-
tractions (96-well plate format) and four real-time PCR
runs per working day. An average of 240 clinical samplesand 40 quality controls were analysed per day. More than
97% of the results were delivered in less than 24 hours,
allowing study participants identified as malaria positive
and lacking any symptoms, to be offered a treatment free
of charge in less than 48 hours.
Quality control performances demonstrated the real-
time PCR screening to have a very good sensitivity and
specificity (100% of both extraction and PCR positive con-
trols being positive, even for the lowest positive control
at 5 parasites/μl and 98.2% of negative controls being
negative). In addition, a satisfactory low interassay coef-
ficients of variation (CV <5%) proves its reproducibility.
As the goal was to develop a malaria diagnostic intended
for large-scale malaria screening studies, the challenge
was to keep the testing price at a minimum. The average
cost for the real-time PCR screening, including DNA
extraction, is estimated at 2.75 USD per sample, whereas
the identification of the four Plasmodium species was per-
formed at 3.75 USD per sample. In addition, the global
cost of the mobile laboratory fully equipped for PCR was
around 200,000 USD.
The main limitations of the PCR developed are related
to the DNA extraction step and, mainly to the volume
of blood analysed. Indeed, for low parasitaemia samples,
it is obvious that the higher the volume of blood col-
lected, the higher the probability to pick up parasites.
When collecting 5 μl of blood, the absolute limit of
detection that can be achieved is one parasite/5 μl
blood (0.2 parasite/μl) if the entire DNA extract is ana-
lysed. In the protocol described here, only one/ten of the
DNA extract is analysed, raising the theoretical detection
limit to 2 parasites/μl blood. When the overall diagnostic
method was assessed on a serial dilution of falciparum
parasites, the last consistently positive dilution was actu-
ally 2 parasites/μl. Increasing the amount of blood tested
during mass screening studies is technically challenging as
blood samples are usually collected from finger prick,
and high throughput testing is facilitated by 96-well
plate format collection. Moreover, the use of a higher
volume of blood would raise another issue: the high
quantities of human DNA that will interfere with para-
site DNA amplification by PCR. To date, no (or little)
information is available on the real distribution of asymp-
tomatic parasite carriers and the minimum parasitaemia
in malaria parasite carriers, therefore, the proportion
of infection being missed by a screening method with
a detection threshold of 2 parasites/μl is impossible to
predict.
Another limitation was related to the specificity of the
real-time PCR species; indeed, samples highly positive for
P. malariae could be misclassified as very weak positive
for P. vivax. Thus, special attention must be paid if one
sample simultaneously presents an early amplification
curve for P. malariae (Ct <18) and a late amplification
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be rare. Finally, regarding the detection of P. knowlesi
infection, the primers designed were found to be unspe-
cific and were removed from the assay. As a consequence,
a P. knowlesi infection would not be missed by the real-
time PCR screening, but would be identified as a P. vivax
infection by the real-time PCR species assays.
Conclusions
The main goal of this work was to develop a diagnostic
approach allowing the analysis of thousands of clinical
samples in field conditions under a restricted time win-
dow. A quality control system was implemented to en-
sure quality of diagnostic results and demonstrated the
robustness and reliability of the methods, even when
working in a limited laboratory space in a remote area.
The operational success of this study proved that the
molecular testing and treatment is logistically achiev-
able in field settings. This new diagnostic tool will allow
the detection of clusters of asymptomatic carriers and will
provide epidemiological information that can be directly
used for improving control strategies. Faster results will be
of great help for staff in the field to track and treat positive
cases. The concept of molecular assays performed in a
mobile laboratory could be extended to other countries
for the detection of malaria asymptomatic cases but also
for the detection of other pathogens where sensitive and
rapid diagnostic assays are needed, especially in remote
areas. Finally, the mobile laboratory is also a tremendous
opportunity to perform malaria parasite culture in the
field, especially for P. vivax, which does not support a
long delay between sample collection and culture.
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